Arrowhead Pharmaceuticals (ARWR) P/S ratio

P/S ratio today
13.5×

Arrowhead Pharmaceuticals (ARWR) trades at 13.5× its revenue per share for fiscal 2026. At the end of fiscal 2026 (September 30, 2026) its P/S ratio was 20.5×. That is 268.8% higher than the 5.6× of fiscal 2025. Figures as of 18 Nov 2026, 06:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
13.5×
P/S ratio, fiscal 2026
20.5×
Change on fiscal 2025
+268.8%
Highest on record
198.5×fiscal 2012
Lowest on record
5.6×fiscal 2025
Fiscal years on record
112011–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Arrowhead Pharmaceuticals P/S ratio, in more detail

Today's figure is 34.3% below the fiscal 2026 year-end.

Across the 11 fiscal year-ends on record (2011–2026), the highest was 198.5× in fiscal 2012 and the lowest 5.6× in fiscal 2025. Today's P/S ratio is higher than at 27% of the 11 fiscal year-ends on record; their median is 20.5×.

History · 11 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Arrowhead Pharmaceuticals P/S ratio, year by year

Arrowhead Pharmaceuticals (ARWR) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today13.5×—$42.99—
202620.5× 268.8% up$65.45$3.19
20255.6×—$34.49$6.20
2024——$19.37$0.03
202312.0× 16.4% down$26.87$2.24
202214.3× 69.4% down$33.05$2.31
202146.8× 5.0% down$62.43$1.33
202049.3× 199.4% up$43.06$0.87
201916.5× 83.4% down$28.18$1.71
201899.3× 874.9% up$19.17$0.19
201710.2×—$4.33$0.43
2016——$7.35—
2015——$5.76—
2014——$14.77—
2013——$5.69—
2012198.5× 92.5% up$2.62$0.01
2011103.1×—$3.90$0.04
2010——$10.50—
2009——$6.65—
2008——$10.40—
2007——$50.50—
2006——$49.90—
2005——$29.90—
2004——$55.00—
2003——$5.85—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Arrowhead Pharmaceuticals and comparable companies
CompanyP/S ratio
Axsome Therapeutics AXSM11.2×
Chemed CHE2.8×
Arrowhead Pharmaceuticals ARWR13.5×
MSA Safety MSA3.6×
CG Oncology CGON1745.3×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on ARWR

Arrowhead Pharmaceuticals, figure by figure

Arrowhead Pharmaceuticals (ARWR) overview: price, valuation and scorecardAll health care companies by market value

Arrowhead Pharmaceuticals P/S ratio: questions and answers

What is Arrowhead Pharmaceuticals's P/S ratio?

Arrowhead Pharmaceuticals (ARWR) trades at 13.5× its revenue per share for fiscal 2026. At the end of fiscal 2026 (September 30, 2026) its P/S ratio was 20.5×. That is 268.8% higher than the 5.6× of fiscal 2025.

Is Arrowhead Pharmaceuticals's P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 27% of the 11 fiscal year-ends on record; their median is 20.5×.

What are the highest and lowest P/S ratio figures on record for Arrowhead Pharmaceuticals?

Across the 11 fiscal year-ends on record (2011–2026), the highest was 198.5× in fiscal 2012 and the lowest 5.6× in fiscal 2025.

How is Arrowhead Pharmaceuticals's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Arrowhead Pharmaceuticals (ARWR) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ARWR/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.